FMP
Jan 21, 2026
U.S. Bancorp (NYSE:USB), a leading financial institution in the United States, continues to demonstrate robust financial health and growth prospects. Here are three key insights from its recent performance:
- Revenue Growth: U.S. Bancorp reported a 5.5% increase in revenue for the quarter ending December 2025, slightly exceeding the Zacks Consensus Estimate.
- Earnings Per Share Increase: The company's earnings per share (EPS) for the quarter were $1.26, representing a significant 24.7% increase from the previous year.
- Net Income Growth: U.S. Bancorp's net income for the quarter reached $2.04 billion, marking a 22.9% increase from the prior-year quarter.
U.S. Bancorp (NYSE:USB) is recognized as the fifth-largest lender in the country, offering a wide range of financial services, including banking, investment, mortgage, and payment services. Competing with other major banks like JPMorgan Chase, Bank of America, and Wells Fargo, U.S. Bancorp has maintained its position in the market.
On January 21, 2026, RBC Capital maintained its "Outperform" rating for U.S. Bancorp, with the stock priced at $54.38. RBC Capital also raised the price target from $57 to $59. This decision reflects confidence in the company's financial performance and growth prospects, as evidenced by its recent earnings report.
U.S. Bancorp reported revenue of $7.37 billion for the quarter ending December 2025, a 5.5% increase from the previous year. This figure slightly exceeded the Zacks Consensus Estimate of $7.32 billion, resulting in a positive surprise of 0.58%. The company's ability to surpass revenue expectations is a positive indicator for investors. The company's earnings per share (EPS) for the quarter were $1.26, up from $1.07 in the previous year, aligning with the consensus EPS estimate of $1.19. This represents a significant 24.7% increase from the same quarter the previous year. Such growth in EPS highlights U.S. Bancorp's strong financial health and potential for future stock performance. U.S. Bancorp's net income for the quarter reached $2.04 billion, marking a 22.9% increase from the prior-year quarter.
For the entire year of 2025, the company achieved earnings of $4.62 per share, exceeding the consensus estimate of $4.55. The net income for the year was $7.6 billion, reflecting a 20.2% increase from the previous year. These results were supported by lower expenses, higher non-interest income, and a robust capital position.
Johnson & Johnson (NYSE:JNJ) is a leading healthcare company known for its wide range of products, including pharmaceuti...
ServiceNow (NYSE:NOW) is a prominent player in the cloud computing industry, specializing in digital workflows and enter...